Researchers using 3-D facial scans to aid diagnosis of children with rare genetic syndrome

October 10, 2018 by Michael Staton, Clemson University
Researchers using 3D facial scans to aid diagnosis of children with rare genetic syndrome
An example of the 3dMD software researchers will use in the project. The technology is powered by anatomically-precise 3D and "temporal-3D" (4D) surface imaging systems. Credit: 3dMD

Clemson University faculty have been awarded a grant from the National Institutes of Health to investigate the use of 3-D imaging that could allow for quicker diagnosis of children with Phelan-McDermid syndrome, a rare genetic condition that causes intellectual and physical disabilities.

Katherine Weisensee, chair of Clemson's sociology, anthropology and criminal justice department, will focus the research on the facial characteristics that are often caused by the syndrome. These characteristics, which often include flattening of the face and a wide brow, have historically been the first signs that lead diagnosticians to identify the syndrome.

Due to the rarity of the syndrome, this diagnosis and associated genetic testing can have families waiting months or years for a conclusive answer. Technology that allows for detailed 3-D scans of a large portion of the patient population could allow Weisensee and her fellow researchers to determine a quantitative "average" for these distinct characteristics, which would speed up diagnosis.

"These scans can give us a concrete idea of the difference between patients with the syndrome and the unaffected population," Weisensee said. "This would lead to a faster diagnosis for the child so that families can seek the interventions they need sooner."

Weisensee will utilize state-of-the-art image capture technology in which six cameras simultaneously capture photos of the patient's face every 1.5 milliseconds. Weisensee will then pick the most representative photos from the resulting string of images, and these images can then be rendered digitally to show an underlying network of data points between eye and nose or mouth and cheek, for example.

By coding facial landmarks and determining an "average" for characteristics across approximately 150 subjects—roughly a 10th of the documented population affected by the syndrome—researchers hope to trace the trajectory of the syndrome's effects and how that trajectory changes based on age, sex and ethnicity.

Weisensee is working with Kara Powder, assistant professor in Clemson's biological sciences department, to get a better sense of the relationship between facial development and gene disruption in the syndrome. These findings could have a bearing on gene therapy in the future.

"By defining the physical changes quantitatively and then charting the underlying genetic reasons for these changes, we can give physicians tools to recognize the syndrome faster and understand it more fully," Weisensee said. "Unfortunately, there is a shortage of professionals who can recognize it quickly, so we hope to provide a shortcut in this area for physicians."

An example of one of the camera systems that 3dMD provides for image capturing. Credit: 3dMD

Curtis Rogers, senior clinical geneticist at the Greenwood Genetic Center, is one of the few geneticists who has extensive experience with the syndrome. He has worked with the Phelan-McDermid Syndrome Foundation since its inception in 1998 and he said it is likely that he has seen more patients with the syndrome than any physician in the world.

In addition to understanding growth trajectory in patients, Rogers said documenting facial landmarks over time might allow physicians to predict the and regression in developmental milestones associated with the syndrome. Between 50 and 85 percent of children with the syndrome develop autism spectrum disorder, and between 25 and 50 percent of children experience developmental regression.

However, the research would be worthwhile if only to achieve a better model for recognizing features that accompany the syndrome. Rogers said diagnosticians must "work their way down the diagnostic chain" to hone in on the syndrome, and this research might allow them to skip some links in that chain.

"Families are often stuck in limbo waiting for information, including what caused it and whether there is risk in a future pregnancy," Rogers said. "Considering it can take up to two years to get this diagnosis in some areas of the country, any project that allows us to get information to a family sooner is worthwhile. I say that not as a geneticist, but as a parent and grandparent."

Weisensee looks forward to applying her expertise of the skull and craniofacial symmetry in a way that will positively impact a specific population, but she also has a personal motivation. She has an uncle with a congenital disease, and although it has had a marked effect on his mental functioning, it has never been diagnosed.

"I feel that once you name a syndrome it helps people understand it and know what to expect," Weisensee said. "I think it would be great to be able to use my work to help shed some light on that mystery for families."

The syndrome is a caused by a deletion or other structural change of a chromosome. The most common characteristics are intellectual disability of varying degrees, delayed or absent speech, symptoms of autism spectrum disorder, low muscle tone, motor delays and epilepsy.

The genetic changes that cause the syndrome vary from person to person and can occur randomly or be inherited from a parent who carries a related genetic change. There is currently no cure or treatment specifically for the , so early detection to manage symptoms effectively is of paramount importance to families.

Explore further: Autism biomarker seen as boon for new treatments

Related Stories

Autism biomarker seen as boon for new treatments

January 11, 2017
Researchers at the UCLA Center for Autism Research and Treatment have identified a signature brain-wave pattern for children with autism spectrum disorder related to a genetic condition known as Dup15q syndrome. The research ...

Newly identified gene mutation results in intellectual disability and developmental delay

April 12, 2018
An international group of researchers led by Cold Spring Harbor Laboratory (CSHL) Assistant Professor Gholson Lyon has identified a new genetic mutation associated with intellectual disability, developmental delay, autism ...

A link between Jacobsen syndrome and autism

September 15, 2014
(Medical Xpress)—A rare genetic disorder known as Jacobsen syndrome has been linked with autism, according to a recent joint investigation by researchers at San Diego State University and the University of California, San ...

New study of Xia-Gibbs syndrome spurs development of patient registry

May 7, 2018
Researchers at the Human Genome Sequencing Center at Baylor College of Medicine have conducted a study of 20 individuals with Xia-Gibbs syndrome, a rare condition that has symptoms of severe developmental delay, sleep apnea, ...

Flow of spinal fluid disrupted in inherited developmental disorder

March 22, 2018
Scientists have pinpointed the mechanism behind hydrocephalus, an accumulation of cerebrospinal fluid around the brain, in an inherited developmental disorder called Noonan syndrome.

New genetic syndrome identified; may offer some answers for puzzled parents

July 6, 2017
Researchers have identified a rare genetic syndrome characterized by intellectual disability, seizures, an abnormal gait and distinctive facial features. The scientists pinpointed variants in the WDR26 gene as causes for ...

Recommended for you

Receiving genetic information can change risk

December 11, 2018
Millions of people in the United States alone have submitted their DNA for analysis and received information that not only predicts their risk for disease but, it turns out, in some cases might also have influenced that risk, ...

HER2 mutations can cause treatment resistance in metastatic ER-positive breast cancer

December 11, 2018
Metastatic breast cancers treated with hormone therapy can become treatment-resistant when they acquire mutations in the human epidermal growth factor receptor 2 (HER2) that were not present in the original tumor, reports ...

Study identifies a key cellular mechanism that triggers pneumonia in humans

December 11, 2018
The relationship between influenza and pneumonia has long been observed by health workers. Its genetic and cellular mechanisms have now been investigated in depth by scientists in a study involving volunteers and conducted ...

How glial cells develop in the brain from neural precursor cells

December 11, 2018
Two types of cells are active in the brain: nerve cells and glial cells. Glial cells have long been regarded primarily as supportive cells, but researchers increasingly recognize that they play an active role in the communication ...

Effect of oral alfacalcidol on clinical outcomes in patients without secondary hyperparathyroidism

December 11, 2018
Treatment with active vitamin D did not decrease cardiovascular events in kidney patients undergoing hemodialysis, according to a research group in Japan. They have reported their research results in the December 11 issue ...

Human antibody discovery could save lives from fungal killer

December 11, 2018
A new way to diagnose, treat and protect against stealth fungal infections that claim more than 1.5 million lives per year worldwide has been moved a step closer, according to research published in Nature Communications.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.